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1. Introduction 
Much work has been done to understand isolated aspects of the immune system and effects 
of immunosuppression in young adults. However there has been little attempt to 
understand changes throughout the entire life-span of an organism, across organs, genetic 
backgrounds and at various scales of biological detail and to assess the effects of 
immunosuppression in old individuals.  
The immune system plays a central role in a number of physiological phenomena to 
maintain the integrity of the individual, by a complex dynamic equilibrium involving 
immunity and inflammation, but also tolerance, in particular during the gestation. 
Disequilibrium can lead to pathological disorders such as auto-immune and infectious 
diseases, cancers and so on. With aging, there is a progressive alteration of the immune 
system and its responses, resulting in immuno senescence and immunodepression. Of 
importance thymic involution and infection contribute to aging of the immune system 
(Gress and Deeks 2009). This leads to less efficient lymphocyte production, activation and 
responsiveness, increased susceptibility to inflammatory responses and autoimmunity and 
decreased responses to infections, tumours and vaccinations, see reviews (2005; 2009; 
Aspinall and Goronzy 2010). 
The most important feature of the immune system is to be able to respond to an almost 
infinite number of antigens and perform immune function to maintain the integrity of the 
individual. This activity depends on the availability of a diverse repertoire of lymphocytes, 
i.e. a collection of lymphocytes, each characterized by its antigen-specific receptor produced 
by random somatic rearrangements of V(D)J gene segments during lymphocyte 
differentiation. The selection constraints are important in particular for the initial 
construction of the immune system (in foetus/newborn), or for reconstitution in 
immunodeficient recipients (Ciupe, Devlin et al. 2009), but also during attrition with aging. 
In this line, recent studies regarding the question of lymphocyte diversity, selection and 
available niches have been discussed (Stirk, Molina-Paris et al. 2008; Ciupe, Devlin et al. 
2009; Leitao, Freitas et al. 2009). Moreover, in old individual mice or humans, clonal 
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expansions are often observed in CD8 T cells, probably as a result of chronic and repeated 
infections. This reduces the diversity of the repertoire (Ahmed, Lanzer et al. 2009), decreases 
the potential to drive an immune response and affects the CD4/CD8 ratio (LeMaoult, 
Messaoudi et al. 2000; Messaoudi, Lemaoult et al. 2004 ; Clambey, van Dyk et al. 2005; 
Goronzy and Weyand 2005; Pawelec, Akbar et al. 2005; Clambey, Kappler et al. 2007) 
reviewed in (Blackman and Woodland 2011). With age CD4 T cells have increased longevity 
(Tsukamoto, Clise-Dwyer et al. 2009) while under normal homeostatic conditions recent 
thymic migrant have to compete with already established mature naïve T cells (Houston, 
Higdon et al. 2011).  
On the life-scale, lymphocyte and lymphoid organ emergence, cell selection and expansion 
during ontogeny are critical features of the immune system construction and determine its 
efficiency at the adult age. Thus, during life, homeostasis is maintained with a dynamic 
equilibrium between diversity and efficiency (naïf vs. effector/memory lymphocytes) with 
two periods of physiological relative immunodeficiency, early in ontogeny and in advanced 
old age. In females, the gestation also represents a relative immunodepressive period 
leading to embryo/foetus acceptance. During the life, dynamic equilibrium ensures complex 
interactions of highly diversified circulating lymphocytes, with high turnover, responsible 
for tolerance and immune protection of the organism, while controlling most pathogens. 
Aging however induces complex and progressive alterations that find their origins at 
different biological scales: organism, organ, cell populations, cells, molecules, genes. Table 
1 summarizes some of these general observations. 
 
 
Table 1. Aging alters immune functions at various biological levels. The levels can interfere 
with each other as depicted by the arrows. 
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Thymic involution is a primary sign of immunological aging at puberty and the reduced 
production of diverse naïve T cells is compensated for in the immune system by the 
proliferation of existing peripheral T cells. In very old humans and mice this leads to 
alteration in the T cell repertoire, appearance of oligoclonal expansions, restricting the 
lymphocyte repertoire (Messaoudi, Lemaoult et al. 2004; Clambey, van Dyk et al. 2005). 
Thymic involution is likely the result of alterations at different levels, aging being related 
to alteration of molecular process as somatic recombination of V-D-J gene, that seems 
related to deficiency in the RAG enzyme, leading to diminution of thymic export (Hale, 
Boursalian et al. 2006), and recent thymic emigrants (Boursalian, Golob et al. 2004). Direct 
alterations of thymocyte proliferation, differentiation process or environmental factors as 
alteration of the thymic epithelium also impact thymocyte differentiation (Thoman 1995; 
Yehuda, Friedman et al. 1998; Andrew and Aspinall 2001). In elderly humans, altered 
homeostasis also participates to decrease ratio of naive/memory and CD4/CD8 cells, with 
senescence of CD4 T cells (Ferrando-Martinez, Ruiz-Mateos et al.).  
Moreover, genetic & epigenetic mechanisms (Yung and Julius 2008) participate to control 
or trigger aging alterations (Dorshkind, Montecino-Rodriguez et al. 2009). We need to 
improve our knowledge on (i) the effects of genetic variability and aging, on lymphocyte 
dynamics population, repertoire selection and related immunodepression and (ii) the effects 
of immunosuppressive treatment in aged mice. Murine models may give some indications 
to better understand similar perturbations in humans or the ways to study and model them. 
In addition to aging that induces immunodepression, various clinical treatments used to 
control many diseases, induce immunosuppression. These treatments are designed to 
control unwanted immune responses, such as inflammation, autoimmunity, graft rejection, 
Graft Versus Host Disease (GVHD). Other treatments designed to fight cancer have the 
drawback to induce immunodepression since they target dividing (tumour) cells but they 
also kill the dividing cells from the immune system. The drawbacks of these treatments are 
their relative low specificity that impacts high dynamics biological system with high cell 
proliferation like lymphoid and haematopoietic systems. Aiming to understand the origins 
of immunodepression during aging or effects upon treatments but also the capacity of the 
immune system to regenerate should be coupled with the study of the immune system in 
homeostatic conditions. This requires specific investigation design related to system biology 
investigation and modelling. 
These different levels of alteration with aging are related to the immune system complexity 
at inter- and intra-cell signalling, receptor diversity, clonotype selection and competition 
(Leitao, Freitas et al. 2009), fluid dissemination through the organism, homeostatic 
regulation and adaptation to a changing environment. In short, the immune system is a 
“complex system”. In general, a complex system is comprised of a great number of 
heterogeneous entities, among which local interactions create multiple levels of collective 
structure and organization. Such systems require analysis at several spatial and temporal 
scales. Scientists are faced with radically new challenges when trying to observe, describe, 
control and develop original theories about these complex biological systems. We 
previously discussed concepts on the evaluation of multiscale systems dynamics, 
fluctuations, stability and resilience (Lavelle, Berry et al. 2008). In addition to looking to 
individual elements and isolated contexts, it is necessary to integrate information and devise 
more holistic approaches (Benoist, Germain et al. 2006; Cohn and Mata 2007). This is 
particularly true of the immune system (Cohen 2007). We recently delineated three 
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challenges1 to study the complexity of the immune systems: (i) the identification of 
lymphocyte populations, (ii) the reconstruction of their dynamics and repertoire selection 
process (iii) the mechanisms involved in the resilience or instabilities to perturbations, 
immune dysfunction in order to improve immuno-intervention strategies. It is obvious that 
the fluctuations related to aging that lead to progressive immunodepression or induced by 
therapeutic immunosuppression are both the consequence of the perturbations of the 
immune system and changes in the initial equilibrium state. Here, we moreover challenge 
the fact that immunosuppression during aging might increase the physiological 
immunodepression. 
A number of studies aiming at providing a global analysis and comprehensive modelling 
of immunological systems have flourished around the world (Rangel, Angus et al. 2004; 
Braga-Neto and Marques 2006; Morel, Ta'asan et al. 2006; Petrovsky and Brusic 2006; 
Borghans and de Boer 2007; Chan and Kepler 2007; Efroni, Harel et al. 2007; Souza-e-Silva, 
Savino et al. 2009). We recently reported on methods and strategies to investigate 
lymphocyte dynamics and repertoires as well as the modelling concepts and formalism 
(Thomas-Vaslin & al. in press). Moreover scientists are faced with data storage and sharing. 
The SIDR initiative to store data with metadata and share them is under current 
development as illustrated in the “T cell and aging” project 2 . 
Interestingly, the high turnover and division of lymphocytes was revealed by the initial 
use of immunosuppressive drugs. In fact the early investigation of lymphoid cell dynamics 
and their precursors are related to the effects of perturbation induced by 
immunosuppression, as irradiation (Sprent, Anderson et al. 1974; Anderson, Olson et al. 
1977; McLean and Michie 1995), following chemotherapy for cancer (Mackall, Fleisher et al. 
1994) or other immunosuppressive drugs used to control the immune system. For example, 
Hydroyurea (HU) is a typical chemotherapy cytostatic treatment that non-specifically 
synchronizes all dividing cells and kills them. This drug particularly affects haematopoietic 
and lymphoid cells having high frequencies of cells in division and thus induces 
immunosuppressive effects. Experiments using HU allowed to reveal the reduced B cell 
functionality post-treatment in mice (Rusthoven and Phillips 1980). Such type of 
experiments and others like transfer experiment or labelling of dividing cells, were used to 
investigate population dynamics in the mouse and revealed the high turnover of B cells 
(Freitas, Rocha et al. 1982) reviewed in Freitas, Rocha et al. 1986). This high dynamic 
immune system display in fact internal activities observed in non-manipulated mice 
(Freitas, Pereira et al. 1989). We have also shown that the cellular environment determines 
the life-span of B cells by selection processes (Thomas-Vaslin and Freitas 1989). This drives 
clonal persistence of B cells through the variable region selection of the BCR (Thomas-
Vaslin, Andrade et al. 1991), contributing to shape the B cell repertoire with aging (Andrade, 
Huetz et al. 1991). In T cells, similar HU immunosuppressive treatment revealed the short 
life expectancy, the continuous renewal and post thymic expansion of T cells (Rocha 1987). 
In fact, lymphocytes are under homeostatic control to regulate the growth and survival of T 
and B cells that occupy and compete for different “ecological niches” (Freitas and Rocha 
2000). Several other methods have allowed to explore T cell dynamics by conditional 
ablation, using depleting antibodies (Qin, Wise et al. 1990; Waldmann and Cobbold 1998; 
Bourgeois and Stockinger 2006) chemical thymectomy (Bourgeois, Hao et al. 2008) or 
                                                 
1 http://roadmap.csregistry.org/tiki-index.php?page=From%20molecules%20to%20organisms 
2 http://sidr-dr.inist.fr/fuge.jsp?idFuge=301796 
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lymphocyte proliferation in immunocompromised recipients. This highly dynamical system 
makes it very sensible and reactive to antigen stimulations, but also to immunosuppressive 
treatments.  
Moreover immunostimulatory and rejuvenation treatments are explored to stimulate the 
immune system in aging or after immunosuppression (Dudakov, Goldberg et al. 2009; 
Lynch, Goldberg et al. 2009). Several factors like Keratinocyte growth factor, Growth 
hormone, cytokines like IL-7, IL-15 or IL2, steroid hormones are implicated in aging process. 
Immuno-stimulatory pathways and rejuvenation treatments are experimented to prevent or 
revert the immunodepression (Zuniga-Pflucker and van den Brink 2007; Dorshkind, 
Montecino-Rodriguez et al. 2009; Mackall, Fry et al. 2011). In particular, some hormones like 
Growth Hormone (GH) and Ghrelin stimulate thymic production, GH normalizing the T 
cell repertoire (Taub, Murphy et al. 2010). 
2. Immunosuppression & aging: Some examples 
Our comprehension of processes of immunodepression with aging or effect of 
immunosuppression requires the understanding of lymphocyte dynamics and the global 
description of lymphocyte populations. The Figure 1 depicts hypothetical T cell population 
subsets in the thymus and peripheral organs, with cell division, process of selection and 
death, differentiation from one population to another one.  
The investigation and modelling of cell population dynamics is often based on knowledge 
obtained from young individuals that can be considered at steady for a short time period in 
absence of intentional immunisation. Alterations of the system and observation of the 
responses to perturbations is also a way to understand the systems properties. As stated 
before, modelling cell population dynamics is an active field of research in systems 
immunology and a plenty of model of T cell dynamics have been proposed (Mehr, 
Globerson et al. 1995; Mehr, Perelson et al. 1997; Efroni, Harel et al. 2007; Asquith, Borghans 
et al. 2009; Dowling and Hodgkin 2009; Souza-e-Silva, Savino et al. 2009). Our mathematical 
model of T cell dynamics is based on a conveyor-belt model of differentiation (Thomas-
Vaslin, Altes et al. 2008) as summarised below in Figure 4. 
Here, we (1) give some examples of the effects of aging on T cell population composition 
and repertoire, (2) show the additive effects of transient or chronic immunosuppression, (3) 
investigated the effects of rejuvenation treatments on T cells repertoire.  
2.1 The physiological aging process & genetic influence  
In order to quantify immunological alterations process through physiological aging we have 
studied the organ distribution, phenotype, repertoire and dynamics of T lymphocytes from 
young (2 months) to aged (25 months) mice. We have also evaluated the effect of genetic 
influences known to determine for example the CD4/CD8 ratio (Kraal, Weissman et al. 
1983). Thus, two different mouse genetic backgrounds identified to provide various quality 
of repertoire selection and aging processes in non-manipulated lab mice C57BL/6 (B6) (H-
2b) and FVB (H-2q) were used.  
2.1.1 T cell populations and cell counts 
Multicolour flow cytometry allows to define the phenotype of single cells and to identify 
thymocyte populations as CD4loCD8lo (DN), CD4hi CD8hi (DP) and mature T cell CD4 and 
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Fig. 1. Schematic hypothetical representation of T cell populations or compartments: a 
compartment could be considered as a green box, with input and output of cells. Inside a 
compartment, cells could be selected to proliferate or to die. In a central compartment such 
as the thymus, diversity of antigenic receptor is obtained by somatic gene rearrangements. 
Compartments could be multiplied according to tissue localisation, cell differentiation steps, 
cell function, receptor antigen repertoire expression… From a steady state equilibrium, 
perturbations can impact one particular or several compartments resizing them. 
CD8 (Fig2A), representing the step of intrathymic T cell differentiation (see Fig. 4 below). 
From FACS we estimated cell percentages (Fig.2B) and numbers (Fig.2C). Similar 
identification of population in spleen and lymph nodes allows discriminating between CD4 or 
CD8 T cells and to estimate their percentages (Fig.2B) as well as the numbers of naïve T cells 
(with low CD44 expression) and antigen experienced cells (high CD44 expression) (Fig2.C).  
In young mice, the CD4 and CD8 percentages are characteristic of each lymphoid tissue as 
thymus, spleen, lymph nodes (Fig.2B). The variability between individuals is low, and a 
typical CD4/CD8 ratio is displayed according to genetic characteristics and organs 
(decreasing from 3.2 in thymus to 1.4 in lymph nodes in B6 mice, while from 5.0 to 2.1 in 
FVB). In old mice, this typical pattern is altered with high variability from mouse to mouse, 
increased proportion of either CD4 or CD8 T cells that correspond to clonal expansions of 
peripheral CD44hi T cells. Thymic involution is accelerated in FVB mice compared to B6 
(Fig.2C) with a 10 times decrease of thymocyte number between 2 months to 2 years. The 
acceleration of thymic involution in FVB might be related to alteration of thymic epithelial 
cell differentiation (Nabarra, Mulotte et al. 2001) that in turn could affect the early 
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differentiation of thymocytes. After thymic differentiation and selection, T lymphocytes 
reach peripheral organs as naïve CD44lo T cells, where they can encounter antigens. In the 
spleen, the number of naïve T cells decreases with aging due to decreased thymic 
production, while those of CD44hi T cells increased due to recruitment by antigenic 
stimulation. With aging the T cell population production is thus perturbed with less naïve 
production compensated in part by effector and memory T cell accumulation. Note that FVB 
young mice have twice the numbers of CD4 naïve T cells compared to B6, while other 
population looks quite similar, suggesting different selection processes and T cell 
population dynamics. With aging, alterations are higher in FVB due to the massive loss of 
naïve CD4 T cells while there is higher accumulation of CD8 CD44hi T cells. Thus, FVB mice 
display an accelerated “immunological aging” compared to B6 mice.  
 
 
Fig. 2. Physiological aging in FVB and B6 mice: (A) Multicolour flow cytometry dot plot 
showing alterations of some cell populations in the thymus of 25 months old mouse 
compared to 2 months old mouse. (B) Percentages of CD4 and CD8 cells observed in 
thymus, spleen and lymph nodes from B6 or FVB in young or old mice. (C) Mean numbers 
of lymphocyte subpopulations in the thymus (upper part) and in the spleen (lower part) as a 
function of age. Graphs were done with JMP software. 
2.1.2 T cell repertoire diversity 
The diversity and variability of the TCR lymphocyte repertoire in young or old mice is an 
important point that is critical for the ability of an individual to respond to a huge variety of 
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antigen. The potential diversity of T lymphocyte in mouse is estimated to 1015 while the size 
of splenic TCR repertoire is estimated to 2x106 with a clonal size of 30-40 cells in young mice 
(Casrouge, Beaudoing et al. 2000). Although initially random rearrangement processes 
favour TCR diversity selection process, selection of particular TCR with germline encoded 
CDR1 and CDR2 sequence interacting with MHC also allows to control thymic selection 
(Scott-Browne, White et al. 2009; Jenkins, Chu et al. 2010). In B6, while there are Mammary 
tumour virus (Mtv) integrations in the genome, the absence of MHC II I-E expression avoids 
the superantigen presentation and prevents the deletion of some Vβ. Thus, in B6 mice the 
repertoire is very diversified compared to other strains that delete some Vβ related to 
superantigen recognition. FVB has a TCRβ chromosomal deletion of Vβ8 and 6 others Vβ 
(Osman, Hannibal et al. 1999).  
 
 
Fig. 3. Evolution of the TCR repertoire from FVB mice through ages in spleen. (A) 
Percentage of Vβ in CD4 versus CD8 T cells in 2 months and 22-26 months old FVB mice 
estimated by FACS. (B) Percentage of VB in CD4 or CD8 T cells in various group of age by 
FACS, (C) Estimation of a perturbation index, with a double hierarchical classification 
following Immunoscope analysis, as exemplified by a Vβ profile showing a Gaussian 
distribution of CDR3 length in young mice and an irregular profile with an oligoclonal 
expansion in 24 month old mice. The red arrows show clonal expansion in two-year old 
mice CD8 T cells. The blue arrow shows clonal deletion as revealed by FACS and 
Immunoscope in same mice 
The TCR repertoire can be assessed either by FACS in individual CD4 or CD8 T cells with 
antibodies specific for each particular Vβ. Alternatively, Immunoscope analysis (Collette 
and Six 2002; Boudinot, Marriotti-Ferrandiz et al. 2008) allows measuring the variable length 
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of the CDR3 region from the TCR involved in antigen recognition, for each Vβ family and to 
estimate the diversity for each Vβ. In young mice, we observed a very low variability in the 
TCR Vβ splenocyte repertoire, as shown for FVB mice in Figure 3. A typical signature of 
young FVB mice can be observed by FACS or immunoscope. In contrast, variability is 
observed in old mice, with occurrence of CD8 CD44hi clonal expansion. This is confirmed by 
measuring CDR3 length expression by Immunoscope, as observance of non-Gaussian peak 
distribution. Some Vβ clones also disappear in old mice. Thus, perturbations are important 
in old mice restricting the diversity of the repertoire, and consequently the possibility to 
respond to antigens. The T lymphocyte repertoire diversity shrinks due to clonal 
amplification and deletion as a consequence of the decrease of de novo thymic production 
and chronic antigenic stimulation by the environmental antigens (Kieper, Troy et al. 2005). 
The magnitude of these alterations depends on aging but also on genetic or epigenetic 
influences since in B6 mice the alterations seem less prominent (see Figure 8). 
2.2 Immunosuppression: The effect of transient conditional depletion of dividing  
T cells on the immune system  
The depletion of dividing T cells leads to immunosuppression. This could be the result of an 
immunotherapy to control the reactivity of the T cells involved in immune responses 
(allograft rejection, Graft versus host disease, autoimmunity, inflammatory diseases), or the 
consequences of anti-tumour chemotherapy targeting dividing tumour cells. Experimental T 
cell depletion can also be used to estimate the natural division, turnover of T cells and to 
evaluate the homeostatic capacity of the immune system to reconstitute. We previously 
studied the effects of transient conditional immunosuppression through the killing of 
dividing T cells by different methods. 
2.2.1 Hydroxyurea 
As reviewed above, Hydroxyurea a cytostatic agent targeting dividing cells, has allowed to 
investigate renewal rates and differentiation of T cells and B cells (Rocha, Freitas et al. 1983; 
Cumano, Vieira et al. 1986; Penit and Vasseur 1988 ; Penit, Vasseur et al. 1988). We have 
shown that HU treatment also induces “immune amnesia”, i.e. this immunosuppressive 
treatments kills lymphocytes involved in the memory maintenance process and thus the 
treatment prevents secondary memory immune response (Bellier, Thomas-Vaslin et al. 
2003). Moreover, we showed that the depletion of dividing cells induced by HU provokes an 
homeostatic perturbation that displace effector/regulatory T cells ratio, inducing dominant 
transplantation tolerance (Giraud, Barrou et al. 2008). Thus, depleting dividing cells is a way 
to manipulate the immune system and immune responses. 
2.2.2 Pharmaco-genetic conditional immunosuppression 
To restrict the effect of chemotherapy to lymphocytes, engineering a specific conditional 
pharmaco-genetic immunosuppression in mice expressing the HSV1-TK suicide (TK) gene 
has allowed to achieve the ablation of B and T cell lineages (Heyman, Borrelli et al. 1989). To 
achieve specific T cell depletion we engineered mice expressing the suicide gene (TK+) 
under a CD4 enhancer and promoter: upon a nucleoside analogue as ganciclovir (GCV) 
treatment in these TK+ transgenic mice, only the CD4 and CD8 T cells that are in division are 
killed, while all other body cells can continue to divide. 
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Transient depletion of dividing T cells to evaluate T cells dynamics 
Using the TK/GCV strategy, we have shown the effect of transient (1 week) dividing T cells 
depletion followed by an homeostatic recovery of the various T cell subsets in the thymus 
and spleen of young adult mice. The mathematical modelling of these experimental data, 
showing depletion and repletion of T cells compartment led us to evaluate the impact of 
dividing cell depletion treatment on T cells, the time necessary to return to pre-treatment 
values. Moreover, it allows to estimate parameters values at the steady state describing the 
continuous T cell differentiation, fluxes, cell division in the thymus and spleen of young 
adult mice (Thomas-Vaslin, Altes et al. 2008). Figure 4 depicts the results of this model in 
young FVB mice and estimation of T cell composition in old mice from our experimental data.  
 
 
Fig. 4. T cell dynamics at steady state in young (3 months old) or middle aged (18 months old) 
FVB mice. The coloured boxes represent the cell populations (white boxes indicate Millions 
cells) differentiating from bone marrow precursors entering the thymus, the number of cell 
cycle (curved arrows), the time (days) for thymic differentiation (left shaded arrows) with 
transit through Double Negative CD4-CD8- (DN), Double Positive CD4+CD8+ (DP) submitted 
to selection process, and finally single positive CD4+CD8- or CD4-CD8+ (SP) stage. Then, 
recent thymic emigrants (RTE) enter the spleen, divide and fill the Long-Lived naïve 
compartment. Antigenic stimulations trigger naïve cells to differentiate in antigen-
experimented T cells (details on the model are in Thomas-Vaslin, Altes et al. 2008). In old mice, 
the thymus was involuted, thus the naïve T cell is considerably reduced while the population 
of Ag-experiment T cells had increased following chronic antigenic challenges. 
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Transient depletion of dividing T cells induces the lack of immunological memory 
maintenance 
We have also studied the effects of a time controlled specific T cell depletion in immune 
mice, using the TK/GCV pharmacogenetic control and shown the lack of secondary 
immune response following such a treatment, confirming the effects observed with HU 
treatment (Bellier, Thomas-Vaslin et al. 2003). 
 
 
Fig. 5. Effect of immunosuppression on the immunological memory maintenance: B6 female 
mice were sensitized on day 0 to male skin antigen through a male skin graft. Female mice 
rejected this first male graft in about 30 days with a typical primary rejection kinetics (yellow 
symbols). After establishment of immune memory, the dividing T cells were depleted for 2 to 
5 weeks. After cessation of treatment a second skin graft is performed and the kinetics of 
rejection is observed: in mice where the depletion of dividing T cells is inefficient (TK-GCV+) 
all skin grafts are rapidly rejected in less than 20 days, with a typical acceleration compatible 
with a second set kinetics (blue symbols). In mice where the depletion of dividing cells is 
efficient (TK+GCV+, orange symbols) the grafts are rejected with a primary set kinetics. 
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Figure 5 depicts an example of T cell immune memory failure in the case of sensitisation 
with an allogeneic skin graft. Similar lack of memory responses were observed after the viral 
infection of mice with the lymphocytic choriomeningitis virus (LCMV). This demonstrates 
that immunological memory is maintained by a pool of T cells in constant division, which is 
sensible to some immunosuppressive treatments. This effect could be a drawback of 
immunosuppressant that might disturb the beneficial immune memory induced by 
vaccination. However, it also suggests that such immunosuppressive treatment could be 
used to target dividing cells responsible of undesirable memory T cell response (as in 
allograft sensitized recipient). 
Specific transient depletion of dividing T cells to control immunopathological T cell 
responses 
Used in pathological situations, the conditional pharmacogenetic immunosuppression 
induced by the TK/GCV system allows to (i) transiently control LCMV infection (Boyer, 
Cohen et al. 2000). (ii) control GVHD (Cohen, Boyer et al. 1997; Cohen, Boyer et al. 1999; 
Cohen, Boyer et al. 1999; Cohen, Saron et al. 2000; Cohen, Boyer et al. 2001). Clinical protocol 
associated with injection of regulatory T cells expressing the TK gene as a safety gene to 
control GVHD are under assessment (Guillot-Delost, Cherai et al. 2008). Applied upon an 
allograft this treatment allows delayed rejection (skin graft) or tolerance of the graft 
(vascularized heart allograft) (Braunberger, Cohen et al. 2000; Braunberger, Raynal-
Raschilas et al. 2000; Thomas-Vaslin, Bellier et al. 2000). In fact, we further showed that the 
depletion treatment (either HU or TK/GCV) induces disequilibrium favouring regulatory T 
cells (Treg) responsible for dominant tolerance able to control islet pancreatic allografts 
rejection (Giraud, Barrou et al. 2008). While aging by itself leads to multilevel alterations and 
finally immunodepression at biological level, little is know about the additive effect of 
clinical immunosuppression during aging. Observations that allograft rejection is decreased 
in old recipient lead to recommendations that older recipient may require less 
immunosuppression than young patients to control allograft rejection and to treat 
autoimmunity or inflammation diseases (Bradley 2002).  
Effect of transient depletion of dividing T cells according to age 
We have compared the kinetics of T cells in mice during and after a transient depletion of 
dividing T cells according to the age of the mice. In young adult mice, the immunosuppressive 
treatment applied during two weeks initially induces the depletion of naïve T (CD44lo) cells in 
FVB mice and in both naïve and effector/memory (CD44hi) T cell in B6 mice (Figure 6).  
Then, homeostatic recovery occurs within two months and both strains recovered initial T 
lymphocyte counts. In contrast, in aged mice the two weeks ganciclovir treatment induces in 
FVB a continuous decrease of naïve T cells counts while effector/memory T cells 
accumulate. In B6 mice the GCV treatment induces less perturbation probably because the 
thymic involution is less prominent than in FVB at the same age. Thus reconstitution of naïve 
T cells can occur post treatment, while accumulation of effector/memory T cells is limited.  
The use of conditional pharmacogenetic immunosuppression has allowed proposing the 
model depicted in Figure 4 from mathematical modelling. Visual computer modelling of T 
cell population dynamics is currently under progress (McEwan, Bersini et al. 2011; McEwan, 
Bersini et al. 2011) to develop our comprehension of cell fluxes between cell compartment 
and organs, cell division. This modelling should allow quantifying parameter values in 
young to aged mice at steady state, but also simulating some treatments, to confirm our 
experimental observations and hypothesis. 
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Fig. 6. Effect of transient pharmacogenetic immunosuppression in the spleen of transgenic 
B6 or FVB mice expressing the HSV1-TK suicide gene in the T cell lineage. Ganciclovir 
treatment is applied for 14 days (grey area) in young (2 months old) or aged (18 months old) 
mice. Box plot and spline curves show the numbers of CD4 CD44lo (continuous green line), 
CD8 CD44lo (continuous blue line), CD4CD44hi (dashed green line) CD8CD44hi (dashed blue 
line) T cells. 
 
 
Fig. 7. Vß TCR repertoire by FACS of spleen cells, showing the percentage of each Vß in 
CD4 vs CD8 T cells, in controls TK-GCV+, TK+GCV- and TK-GCV- mice (TK/GCV 
depletion= 0) and in depletion sensitive TK+GCV+ mice (TK/GCV depletion =1). 
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The analysis of the TCR Vß repertoire following the pharmacogenetic 
immunosuppression (Figure 7) revealed major alterations in the CD8 T cells from aged 
FVB mice with either oligoclonal expansion (representing up to 60 millions of cells) or 
partial clonal deletion (manuscript in preparation). In contrast, in B6 mice the alterations 
following treatment are more limited although detectable. Again the slower 
“immunological aging” of B6 mice seems to preserve homeostatic recovery and the T cell 
repertoire diversity. 
2.3 Prevention of aging and immunodepression 
IL-2 has been shown to have a dual role in CD8 memory maintenance, being able to inhibit 
the proliferation of CD8 memory T cells (Dai, Konieczny et al. 2000) via down regulation of 
the γc chain expression of its receptor, increasing apoptotic cell death (Li, Demirci et al. 
2001). The growth of very large CD8 T cell clones observed in old mice was attributed to 
cytokine deregulation, IL-15 being stimulatory, while IL-2 is inhibitory (Ku, Kappler et al. 
2001). IL-2 is a cytokine that acts centrally and peripherally to increase CD4 naïve T cell 
numbers (Foussat, Bouchet-Delbos et al. 2004). There is a defect of IL-2 production by CD4 T 
cells from aged mice, reducing their expansion capacity (Haynes, Linton et al. 1999). IL-2 is 
also necessary to maintain CD4+CD25+ regulatory T cells that control CD4 T cell 
homeostasis (Almeida, Legrand et al. 2002). CD4+CD25+ regulatory T cells are involved in 
IL-2 mediated inhibition of memory CD8 T cells, reducing their division (Murakami, 
Sakamoto et al. 2002). 
Regulatory T cells were shown to accumulate with aging contributing to decrease immune 
responses. However the augmentation of suppressive function is not due to 
CD4+CD25+Foxp3+ T cells but to CD4+CD25- Foxp3+ T cells that appear with aging 
(Nishioka, Shimizu et al. 2006). Since a lack of IL-2 secretion is reported in old individuals, 
with deficiency in CD4 help, IL-2 treatments were assessed and shown to increase Treg cell 
numbers in lymphopenic individuals (Zhang, Chua et al. 2005). The role of Treg in the 
prevention of repertoire alteration was also shown in the case of lymphopenia induced 
proliferation (Winstead, Reilly et al.). Treg also modulate the effector function of CD8 by 
competing for IL-2 (McNally, Hill et al. 2011). IL-2 also has positive effect to control T cell 
homeostasis in autoimmunity (Humrich, Morbach et al.). In NOD type-1 diabetic mice, IL-
2 can prevent or reverse autoimmunity, by stimulation of Tregs (Grinberg-Bleyer, Baeyens 
et al.). In infectious diseases, HIV infected patient IL-2 treatment induces an increase of 
thymic export (Carcelain, Saint-Mezard et al. 2003) and induces a peripheral CD4 T cell 
expansion by limiting CD4 proliferation and increasing CD4CD25+ subset (Sereti, 
Anthony et al. 2004).  
To prevent the effects of aging homeostatic deregulation and TCR repertoire alterations, we 
tested the effect of IL-2 or transfer of regulatory T cells (CD4+CD25+) injected in middle-
aged B6 mice (15-month old) (Figure 8). Both treatments prevent clonal alterations as 
revealed by FACS analysis of TCRVB repertoire at the age of 24-28 months. Non-treated B6 
mice developed by 24-28 months oligoclonal expansions essentially in CD4 T cells and loose 
CD8 T cell clones. IL-2 treated mice have lower CD4 clonal expansions, that are absent in 
Treg treated mice and repertoire looks “younger”. Both treatments limited the decrease of 
CD8 cell clones. Note that at variance with FVB mice, in B6 mice the aging of the repertoire 
is delayed, and that oligoclonal expansions concern mostly CD4 T cells in B6 but CD8 T cells 
in FVB.  
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Fig. 8. Vß TCR repertoire by FACS of spleen cells from B6 mice, showing the number of each 
Vß in CD4 vs. CD8 T cells, in non treated B6 mice according to age, and in B6 mice that 
received an IL-2 treatment or an injection of regulatory T cells (CD25+) at the age of 15 
months and are analysed at the age of 24-28 months. 
3. Conclusions 
We pointed out that the different initial T cell numbers available according to age and 
genetic background determines the kinetics of depletion and recovery in B6 and FVB mice. 
This suggests that the T cell dynamics and turnover differs according to genetic influence. 
FVB mice have an accelerated immunological aging, with accelerated thymic involution and 
finally accumulation of CD8 clonal T cell expansions by 22 months. The transient depletion 
of dividing T cells temporarily disturb the dynamic T cell equilibrium of young mice of both 
genetic background, with a return to steady-state values and no alteration in repertoire 
diversity. However, in middle-aged mice the effect of the transient depletion can be more 
dramatic: in FVB mice it leads to accelerated occurrence of CD8 T cell clones. In B6 mice, the 
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long term consequences of treatment are less important, most likely because the thymus is 
more productive at the same age. However, we also observed that a preventive treatment by 
serial injection of IL-2 or a single injection of Treg cells in middle aged mice can successfully 
prevent the natural occurrence of repertoire alterations.  
Our work allows us to observe the physiological aging that impacts on the quality and 
quantity of T cells in the central and peripheral organs as well as on the diversity of the 
repertoire. It indicates that some immunosuppressive treatments inducing a homeostatic 
disturbance of the immune systems might accelerate the aging of the T cell composition and 
reduce the TCR repertoire diversity, while some immunostimulatory treatment or 
regulatory T cells might prevent such alterations. As underlined before, several biological 
scales are involved in these processes and the variability observed between genetic 
background, ages of the same individual at the level of cell population, cells or TCR cellular 
or molecular repertoire have to be evaluated.  
Use of systems immunology approaches as multidimensional statistical models (Pham, in 
preparation) and computer models (McEwan, in preparation) are novel approaches that will 
give a more thorough evaluation of complex T cell population dynamics to be able to 
simulate the physiological behaviour and effects of perturbations. 
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